Sign up to save your podcasts
Or
Share How Anti-Obesity Drugs are Redefining Pharma and Wellness with David Ricks and Fatima Cody Stanford
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How Anti-Obesity Drugs are Redefining Pharma and Wellness with David Ricks and Fatima Cody Stanford
Two of the leading experts on anti-obesity drugs say the drugs are heralding a new era in medicine and could soon be used to treat a raft of other conditions.
David Ricks, the chair and chief executive of Eli Lilly, and Dr. Fatima Cody Stanford, obesity medicine physician at Massachusetts General Hospital/Harvard Medical School, talk through the groundbreaking role of GLP-1 medications in transforming the treatment of obesity, and how the drug could potentially be used to treat alcohol use disorder or other addictions.
This interview was with Andrew Ross Sorkin of The New York Times at the annual DealBook Summit and recorded live in front of an audience at Jazz at Lincoln Center. Read more about highlights from the day at https://www.nytimes.com/live/2024/12/04/business/dealbook-summit-news
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
View all episodes
By The New York Times
4.5
5050 ratings
Two of the leading experts on anti-obesity drugs say the drugs are heralding a new era in medicine and could soon be used to treat a raft of other conditions.
David Ricks, the chair and chief executive of Eli Lilly, and Dr. Fatima Cody Stanford, obesity medicine physician at Massachusetts General Hospital/Harvard Medical School, talk through the groundbreaking role of GLP-1 medications in transforming the treatment of obesity, and how the drug could potentially be used to treat alcohol use disorder or other addictions.
This interview was with Andrew Ross Sorkin of The New York Times at the annual DealBook Summit and recorded live in front of an audience at Jazz at Lincoln Center. Read more about highlights from the day at https://www.nytimes.com/live/2024/12/04/business/dealbook-summit-news
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
More shows like DealBook Summit
View all
The Book Review
3,861 Listeners
Popcast
1,443 Listeners
Modern Love
8,752 Listeners
Pivot
8,807 Listeners
Inside The Times
141 Listeners
Channels with Peter Kafka
549 Listeners
The Run-Up
2,062 Listeners
The Daily
111,530 Listeners
Change Agent
1,465 Listeners
Caliphate
12,629 Listeners
Charm City
300 Listeners
The David Rubenstein Show
145 Listeners
Interesting Times with Ross Douthat
6,604 Listeners
1619
31,603 Listeners
The Latest
469 Listeners
The Candidates
52 Listeners
Jungle Prince
2,287 Listeners
The Choice
380 Listeners
The Prof G Pod with Scott Galloway
5,073 Listeners
Rabbit Hole
6,670 Listeners
Hard Fork
5,351 Listeners
The Ezra Klein Show
15,263 Listeners
Day X
1,492 Listeners
The Interview
1,422 Listeners
The Run-Up (2016)
7 Listeners
On with Kara Swisher
3,141 Listeners
Sway
57 Listeners
The Argument
16 Listeners
Prof G Markets
846 Listeners
The Opinions
371 Listeners
Raging Moderates with Scott Galloway and Jessica Tarlov
927 Listeners